Journey Medical (DERM) Enterprise Value (2020 - 2026)

Journey Medical has reported Enterprise Value for 7 years, with the latest figure at -$27.2 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 29.18% year-over-year to -$27.2 million; the trailing twelve-month figure through Mar 2026 stood at -$27.2 million (down 29.18% YoY), and the FY2025 full-year result was -$24.1 million, down 18.69% from the prior year.
• Enterprise Value for Q1 2026 stood at -$27.2 million, down from -$24.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$17.0 million in Q2 2023, with the low at -$41.3 million in Q1 2022.
• Historically, Enterprise Value has averaged -$26.5 million across 5 years, with a median of -$24.7 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value tumbled 60.87% — and 2023, when it surged 55.51%.
• Journey Medical's Enterprise Value stood at -$32.0 million in 2022, then climbed by 14.25% to -$27.4 million in 2023, then advanced by 26.0% to -$20.3 million in 2024, then declined by 18.69% to -$24.1 million in 2025, then decreased by 12.94% to -$27.2 million in 2026.
• The last three Enterprise Value figures came in at -$27.2 million (Q1 2026), -$24.1 million (Q4 2025), and -$24.9 million (Q3 2025), per Business Quant data.